1. Home
  2. Analysis
  3. Imitrex
  4. Weight-loss

Imitrex and Weight loss - a phase IV clinical study of FDA data

Summary:

Weight loss is reported as a side effect among people who take Imitrex (sumatriptan succinate), especially for people who are female, 40-49 old, also take Ambien, and have Depression.

The phase IV clinical study analyzes which people have Weight loss when taking Imitrex. It is created by eHealthMe based on reports of 15,815 people who have side effects when taking Imitrex from the FDA, and is updated regularly.

What is Imitrex?

Imitrex has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 17,149 Imitrex users. Check the latest studies of Imitrex.

What is Weight loss?

Weight loss is found to be associated with 1,458 drugs and 2,291 conditions by eHealthMe. Check the latest studies of Weight loss.

On Apr, 10, 2026

15,815 people reported to have side effects when taking Imitrex.
Among them, 57 people (0.36%) have Weight loss.

Could Imitrex cause Weight loss?

Among these 57 people:

What is the gender of people who have Weight loss when taking Imitrex? *

  • female: 91.23 %
  • male: 8.77 %

What is the age of people who have Weight loss when taking Imitrex? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 1.82 %
  • 20-29: 7.27 %
  • 30-39: 12.73 %
  • 40-49: 29.09 %
  • 50-59: 25.45 %
  • 60+: 23.64 %

What are other drugs people take besides Imitrex? *

  1. Ambien: 28 people, 49.12%
  2. Celebrex: 17 people, 29.82%
  3. Xanax: 16 people, 28.07%
  4. Abilify: 14 people, 24.56%
  5. Seroquel: 13 people, 22.81%
  6. Prozac: 12 people, 21.05%
  7. Depakote: 12 people, 21.05%
  8. Lorazepam: 12 people, 21.05%
  9. Vicodin: 12 people, 21.05%
  10. Allegra: 11 people, 19.30%

What are other side effects people have besides Weight loss? *

  1. High Blood Pressure: 25 people, 43.86%
  2. High Blood Cholesterol: 22 people, 38.60%
  3. Dyspnea (difficult or laboured breathing): 21 people, 36.84%
  4. Stress And Anxiety: 19 people, 33.33%
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 19 people, 33.33%
  6. Weakness: 18 people, 31.58%
  7. Joint Pain: 18 people, 31.58%
  8. Hyperlipidaemia (presence of excess lipids in the blood): 17 people, 29.82%
  9. Depression: 17 people, 29.82%
  10. Injury: 16 people, 28.07%

What are the existing conditions these people have? *

  1. Depression: 13 people, 22.81%
  2. Headache (pain in head): 10 people, 17.54%
  3. Bipolar Disorder (mood disorder): 9 people, 15.79%
  4. Pain: 6 people, 10.53%
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints): 6 people, 10.53%
  6. Metastases To Bone (cancer spreads to bone): 6 people, 10.53%
  7. Stress And Anxiety: 5 people, 8.77%
  8. Insomnia (sleeplessness): 5 people, 8.77%
  9. Hot Flush (sudden feelings of heat): 4 people, 7.02%
  10. Breast Cancer Metastatic: 4 people, 7.02%

* Approximation only. Some reports may have incomplete information.

Do you take Imitrex and have Weight loss?

- Check whether Weight loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Imitrex:

Weight loss treatments and more:

How severe was Weight loss and when was it recovered:

Expand to all the drugs that have ingredients of sumatriptan succinate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Imitrex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight loss:

Browse all the conditions that are associated with Weight loss:

How the study uses the data?

The study uses data from the FDA. It is based on sumatriptan succinate (the active ingredients of Imitrex) and Imitrex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.